NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
Details
- Buyer
- NHS England
- Value
- £37,954,000
- Topic
- Pharmaceutical products
- Published
- 2 October 2025
- Submission
- 31 October 2025
- Source
- uk:find_a_tender
Tender description
Project title: NHS National Framework for Transition Products (Apremilast, Pazopanib and Dapagliflozin) commencing 1st February 2026 Offer reference number: CM/TNS/25/5735 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin Lot 1 DLN/DNW: 01/02/2026 to 31/01/2027 (12 months) Lot 2 DLS/DNE: 01/02/2026 to 31/01/2027 (12 months) Lot 3 DCE/DSW: 01/02/2026 to 30/09/2027 (20 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Timeline
- Completed: Tender published2 October 2025Current notice
- Completed: Submission date31 October 2025
About the buyer
NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Much of this procurement flows through framework agreements and the Crown Commercial Service. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.
Clinical services are commissioned directly or through the Provider Selection Regime.
Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
18 similar open tenders
See more open tenders related to NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin.
- Open tender
NP93827 Seasonal Influenza Vaccine
- Open tender
NP93827 Seasonal Influenza Vaccine
- Open tender
Formalin Biopsy Pots
- Open tender
Hepatitis C Medicines
- Open tender
NHS National Framework for Lenvatinib
Related topics
Topics related to NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin, ranked by notice volume.
- 45,280£7.7tn
Related buyers
Buyers similar to NHS England.
- 515£249.7m
- 438£15.3bn
- 414£111.6m
- 390£652.7m
- 329£25.1bn
- 296£1.6bn
- 293£1.3bn
- 284£3.1bn
- 154£121.9m
- 148£1.0bn
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.